SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001261734-08-000021
Filing Date
2008-05-09
Accepted
2008-05-09 14:10:26
Documents
4
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2008 form10q2ndqtr08.htm 10-Q 448634
2 EXHIBIT 31.1 - CEO CERTIFICATION ex311-2ndqtr08.htm EX-31.1 12991
3 EXHIBIT 31.2 - CFO CERTIFICATION ex312-2ndqtr08.htm EX-31.2 12645
4 EXHIBIT 32.1 - CEO/CFO CERTIFICATION ex321-2ndqtr08.htm EX-32.1 8196
  Complete submission text file 0001261734-08-000021.txt   484058
Mailing Address 23811 INVERNESS PLACE LAGUNA NIGUEL CA 92677
Business Address 23811 INVERNESS PLACE LAGUNA NIGUEL CA 92677 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 08817622
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1